This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Biosense Webster wins judgment against US tying case over catheters

( April 6, 2022, 22:31 GMT | Official Statement) -- MLex Summary: Innovative Health failed to establish any legally cognizable relevant markets in support of its US antitrust claims against Biosense Webster, according to a court order that was recently made public. Innovative accused Biosense of illegally tying the purchase of catheters to the ongoing operation of its CARTO 3 cardiac mapping system. US District Judge James V. Selna determined that there is not sufficient customer demand for each of the two products to show separate markets and the fact that most hospitals have stopped providing their own support in favor of accepting free support offered by Biosense shows that it is a value-add for Biosense customers.See document below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections